About Otsuka
Corporate Profile
Corporate profile
| Company name | Otsuka Pharmaceutical Co., Ltd. |
|---|---|
| Head office | 2-9, Kanda-Tsukasamachi, Chiyoda-ku, Tokyo 101-8535, Japan |
| Date established | August 10, 1964 |
| President and Representative Director | Makoto Inoue |
| Capital | 20 billion yen |
| Employees | 5,907 (as of December 31, 2024) |
| Business description | Manufacture, sale, export and import of pharmaceuticals, clinical testing equipment, medical device and equipment, food products, cosmetics, and other related products. |
| Business premises | 15 branch offices, 48 district office (in Japan) |
| Research facilities | 4 locations (in Japan) |
| Factories | 8 production sites (in Japan) |
Net Sales
| Total for Otsuka Pharmaceutical and major subsidiaries in fiscal year 2024*1 |
1,688.2 billion yen |
|---|---|
| Of which Pharmaceutical Business | 1,226.5 billion yen |
| Of which Nutraceutical Business | 461.7 billion yen |
- *1The major subsidiaries include Otsuka America Pharmaceutical, Inc., Otsuka Pharmaceutical Europe Ltd., Pharmavite LLC, and Nardobel SAS.
Otsuka Pharmaceutical is a wholly owned subsidiary of Otsuka Holdings Co., Ltd. Please see the Investor relations informationof our parent company Otsuka Holdings for financial statements from the Otsuka Group.